Press Release Eywa Pharma Announces $30M Investment from Eight Roads Ventures, F-Prime Capital and Envestor Ventures... More Info More Info Products With our extensive experience in portfolio identification and abundant market intelligence, we have built a well-balanced portfolio consisting More Info More Info Markets Currently our focus is on highly regulated markets like US, Europe, Canada, Australia and South Africa. Eywa will soon... More Info More Info
Partnerships We have always believed in the adage “Life is a 2-way street”…it is this approach that has helped us build... More Info More Info Manufacturing We are in the process of creating manufacturing capacities either organically or inorganically... More Info More Info Quality and Systems At Eywa, Quality is a way of life. Our highest priority is Quality by Design (QbD) not only for product... More Info More Info People At Eywa Pharma, we believe that people make all the difference…All human beings want to be... More Info More Info
Careers A state-of-the art world class generic formulation R&D facility in Chennai, India has been set up with the capability to develop various finished dosage forms. This facility has pilot scale manufacturing capabilities, fully compliant to cGMP norms... More Info More Info Contact Info EYWA PHARMA PRIVATE LIMITED, 9TH Floor, TICEL BIO PARK PHASE II, NO.5, CSIR ROAD, TARAMANI, CHENNAI – 600 116, TAMILNADU, INDIA. Tel : +91 44 6613 2500 Email us
Loading...